Efficacy Study in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
presented at the 2019 International Society for Neurofeedback and Research (ISNR) Conference, Denver, CO, USA
Click below to view poster:
Background. Neurofeedback is commonly regarded as an adjunctive treatment for ADHD, and randomized controlled trials have shown significant benefit attributable to this intervention (Arns, Ridder, Strehl, Breteler, & Coenen, 2009; Micoulaud-Franchi et al., 2014; Lofthouse, Arnold, Hersch, Hurt, & DeBeus, 2012). The present study is a controlled trial to evaluate the specific benefit of neurofeedback training using Myndlift, a clinician-guided wearable, mobile neurofeedback system. Methods. Nineteen (19) participants (all male, ages 8-15) diagnosed with ADHD were recruited. The intervention group (n=12) engaged in theta/beta neurofeedback training three to four times a week for 9 weeks, totaling an average of 21 sessions per participant.